as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹538.3
Change
-6.8 (-1.25%)
Open
₹545.1
Prev. Close
₹545.1
Day High
₹545.85
Day Low
₹536.0
Volume Analysis
Traded
62,517
Delivered
56,908
Delivery %
91.03%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year EPS growth (30.9%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹553.95 | ₹549.9 | ₹544.1 | ₹540.05 | ₹534.25 | ₹530.2 | ₹524.4 |
| Fibonacci | ₹549.9 | ₹546.14 | ₹543.81 | ₹540.05 | ₹536.29 | ₹533.96 | ₹530.2 |
| Camarilla | ₹541.01 | ₹540.11 | ₹539.2 | ₹540.05 | ₹537.4 | ₹536.49 | ₹535.59 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-23.65%
1 Week
-1.52%
1 Month
-3.37%
3 Months
-11.72%
6 Months
-28.13%
1 Year
-23.02%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹699.57
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.38%
Net margin 5.78% × asset turnover 0.96x × equity multiplier 1.69x
Company Overview
Sector
Chemicals
Market Cap
₹1,604 Cr
P/E (TTM)
13.1
ROE
12.0%
Book Value
₹454.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Insecticides (i) Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 56/100. The strongest factor is Financial Strength (100/100), while Momentum (17/100) is the weakest area to weigh before deciding. Strong 3-year EPS growth (30.9%).
TopFund Score — Fundamentals Quality
56/100 — AverageData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −The company has delivered a poor sales growth of 8.55% over past five years.
- −Company has a low return on equity of 12.0% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Earnings Call Transcript for quarter and half year ended September 30, 2026
Newspaper advertisement of Unaudited Financial Results for the Second Quarter and half year ended September 30, 2026.
Audio recording of Q2 and H1 FY2027 earnings call for September 30, 2026 results available online.
Insecticides India reported Q2 FY27 revenue of Rs 686 crore and H1 FY27 PAT of Rs 100 crore.
Earning Presentation for Q2 &H1 of FY 2026-27 Results
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 696 | 358 | 272 | 657 | 627 | 358 | 359 | 691 | 638 | 385 | 426 | 612 | 686 |
| Expenses + | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 | 401 | 544 | 594 |
| Operating Profit | 82 | 26 | 9 | 72 | 90 | 31 | 28 | 85 | 89 | 27 | 25 | 68 | 92 |
| OPM % | 12.0% | 7.0% | 3.3% | 11.0% | 14.0% | 9.0% | 8.0% | 12.0% | 14.0% | 7.0% | 6.0% | 11.0% | 13.0% |
| Other Income + | 0 | 1 | 5 | 3 | 2 | 0 | 3 | 4 | 3 | 1 | 5 | 6 | -1 |
| Interest | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 | 4 | 5 | 7 |
| Depreciation | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 | 9 | 10 | 10 |
| Profit before tax | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 | 16 | 59 | 75 |
| Tax % | 26.0% | 28.0% | -106.0% | 25.0% | 25.0% | 22.0% | 37.0% | 25.0% | 25.0% | 27.0% | 27.0% | 25.0% | 25.0% |
| Net Profit + | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 | 12 | 44 | 56 |
| EPS in Rs | 18 | 4 | 3 | 17 | 21 | 6 | 5 | 20 | 20 | 4 | 4 | 15 | 19 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 20 | 0 | -10 | 3 | -10 | 0 | 32 | 5 | 2 | 8 | 19 | -12 | 8 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 893 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,140 | 2,109 |
| Expenses + | 782 | 814 | 882 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,804 | 1,779 | 1,913 | 1,896 |
| Operating Profit | 111 | 92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 227 | 213 |
| OPM % | 12.0% | 10.0% | 11.0% | 14.0% | 16.0% | 11.0% | 11.0% | 11.0% | 7.0% | 8.0% | 11.0% | 11.0% | 10.0% |
| Other Income + | 0 | 0 | 7 | 3 | 1 | 3 | -2 | 3 | 1 | 10 | 8 | 12 | 11 |
| Interest | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 17 | 20 |
| Depreciation | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 36 | 38 |
| Profit before tax | 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 187 | 165 |
| Tax % | 14.0% | 21.0% | 27.0% | 29.0% | 20.0% | 22.0% | 21.0% | 24.0% | 25.0% | 23.0% | 26.0% | 25.0% | — |
| Net Profit + | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 139 | 122 |
| EPS in Rs | 19 | 13 | 19 | 27 | 40 | 28 | 30 | 36 | 21 | 34 | 49 | 48 | 42 |
| Dividend Payout % | 0.0% | 10.0% | 7.0% | 5.0% | 3.0% | 10.0% | 4.0% | 6.0% | 14.0% | 9.0% | 4.0% | 4.0% | — |
| Sales growth | — | 1 | 10 | 8 | 11 | 14 | 4 | 6 | 20 | 9 | 2 | 7 | 3 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,191 | 1,291 |
| Borrowings + | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 157 | 248 |
| Other Liabilities + | 308 | 321 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 623 | 661 |
| Total Liabilities | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 | 2,229 |
| Fixed Assets + | 210 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 370 | 372 |
| CWIP | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 130 | 159 |
| Investments | 3 | 3 | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 29 | 25 |
| Other Assets + | 670 | 684 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,472 | 1,673 |
| Total Assets | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 | 2,229 |
| Equity Capital | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 | 29 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 | 100 |
| Cash from Investing Activity + | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 | -86 |
| Cash from Financing Activity + | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 | 18 |
| Net Cash Flow | -4 | 4 | 0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 | 31 |
| Free Cash Flow | -40 | 67 | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 | 8 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 1 | 108 | 19 | 140 | -54 | 175 | 120 | 103 | 16 | 124 | 61 | 69 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 14.32% | 14.4% | 14.41% | 13.36% | 13.34% | 13.63% | 13.32% | 13.69% | 13.85% | 13.94% | 14.04% | 14.01% |
| Promoters | 72.16% | 72.16% | 72.16% | 72.16% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% |
| FII | 4.41% | 4.31% | 4.36% | 5.43% | 5.13% | 4.5% | 4.65% | 4.51% | 4.46% | 4.5% | 4.4% | 4.44% |
| DII | 9.12% | 9.14% | 9.08% | 9.06% | 9.24% | 9.59% | 9.72% | 9.5% | 9.4% | 9.27% | 9.26% | 9.26% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Insecticides (i) Ltd (this stock) | 1,604 | 13.1 | 1.2 | 12.0% |
| Oriental Aromatics Ltd | 1,596 | 154.0 | 2.38 | 0.5% |
| Bhageria Industries Ltd | 1,594 | 14.1 | 2.35 | 7.03% |
| Bharat Rasayan Ltd | 1,648 | 11.8 | 1.24 | 12.2% |
| Nitta Gelatin India Ltd. | 1,544 | 12.8 | 2.73 | 21.0% |
| Vidhi Spclty F Ingrdnts L | 1,533 | 25.4 | 4.23 | 15.6% |
| I G Petrochemicals Ltd | 1,691 | 10.0 | 1.15 | 0.16% |
Which Mutual Funds Hold Insecticides (i) Ltd?
Frequently Asked Questions about Insecticides (i) Ltd
Insecticides (i) Ltd (INSECTICID) closed at ₹538.3 on NSE on 19 November 2026, down 6.8 (1.25%) from the previous close.
Insecticides (i) Ltd trades on the NSE (National Stock Exchange of India) under the symbol INSECTICID.
Insecticides (i) Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 13.1.
Insecticides (i) Ltd has a dividend yield of 0.92%.
Insecticides (i) Ltd's 52-week high is ₹776.0 and its 52-week low is ₹500.0.
Insecticides (i) Ltd has a market capitalisation of ₹1,604 crore.
Insecticides (i) Ltd has a TopFund Quality Score of 56/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Insecticides (i) Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.